Atlas Trials

Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis

Clinical trial NCT01552044 · COMPLETED

Trial details

NCT number
NCT01552044
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Central Serous Chorioretinitis
Start date
2012-01-01
Primary completion
2013-01-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.